National Comprehensive Cancer Network (NCCN) Guidelines® Insights - Central Nervous System Cancers, Version 2.2022
English
Recorded Courses
hosted by National Comprehensive Cancer Network (NCCN)
hosted by National Comprehensive Cancer Network (NCCN)
attend it anywhere online
category
Medicine, Healthcare Management, Nursing
Oncology, Neurology
price
Free
National Comprehensive Cancer Network (NCCN) Guidelines® Insights - Central Nervous System Cancers, Version 2.2022 is organized by National Comprehensive Cancer Network (NCCN) and will be held from Jan 10, 2023 - Jan 10, 2024.,,Description:,The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of the following adult CNS cancers: glioma (WHO grade 1, WHO grade 2–3 oligodendroglioma [1p19q codeleted, IDH-mutant], WHO grade 2–4 IDH-mutant astrocytoma, WHO grade 4 glioblastoma), intracranial and spinal ependymomas, medulloblastoma, limited and extensive brain metastases, leptomeningeal metastases, non–AIDS-related primary CNS lymphomas, metastatic spine tumors, meningiomas, and primary spinal cord tumors. The information contained in the algorithms and principles of management sections in the NCCN Guidelines for CNS Cancers are designed to help clinicians navigate through the complex management of patients with CNS tumors. Several important principles guide surgical management and treatment with radiotherapy and systemic therapy for adults with brain tumors. The NCCN CNS Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding molecular pro?ling of gliomas.,,Learning Objectives:,Upon completion of this activity, participants will be able to:,• Integrate into professional practice the updates to the NCCN Guidelines for Central Nervous System Cancers,• Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Central Nervous System Cancers,,Additional details will be posted as soon as information is available.